Contemporary HCV pangenotypic DAA treatment protocols are exclusionary to real world HIV-HCV co-infected patients

Maughan, A; Sadigh, K; Angulo-Diaz, V; Mandimika, C; Villanueva, M; Lim, JK; Ogbuagu, O

Ogbuagu, O (reprint author), Yale Univ, Yale AIDS Program, Infect Dis Sect, Sch Med, 135 Coll St,Suite 323, New Haven, CT 06510 USA.

BMC INFECTIOUS DISEASES, 2019; 19 ():

Abstract

BackgroundTreatments for Hepatitis C virus (HCV) infection have vastly improved over the past few decades with current regimens now offering pangenoty......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索